Navigation Links
YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING
Date:5/28/2009

MISSISSAUGA, ON, May 28 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that a poster presentation will report results from a randomized trial of nimotuzumab (aka BIOMAb/TheraCIM/h-R3) in patients with head and neck cancer conducted by Biocon Limited (Bangalore, India), a licensee of CIMAB SA, YM's licensor, at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Orlando, Florida from May 29 to June 2, 2009.

The poster entitled "A phase IIb 4-arm open-label randomized study to assess the safety and efficacy of h-R3 monoclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with advanced (stage III or IVA) inoperable head and neck cancer (abstract # 6041)" will be presented in the Head and Neck Cancer general poster session on Monday, June 1 from 8:00AM until 12:00PM on Level 2 in West Hall C.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development. The Company is currently developing two late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM), and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemorad
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Verenium Corporation (Nasdaq: ... focused on the development and commercialization of high-performance enzymes, ... Chief Financial Officer, will present at two upcoming conferences. ... Black will present at the Second Annual Marcum LLP ... Grand Hyatt Hotel in New York City.  The presentation ...
(Date:5/23/2013)... African Ancestry , Inc., ... of African descent, today announced new product enhancements ... of all races, myDNAmix determines various ancestries included ... Indigenous Americas (Native American), East Asia, West Sub-Saharan ... , Originally launched in late 2011, the enhanced ...
(Date:5/23/2013)... NH (PRWEB) May 23, 2013 Ralph Huber, ... of their emergency management products and emergency survival kits ... , This announcement was made at the quarterly executive board ... with a moment of silence for the Oklahoma tornado victims ... that the quality of their emergency kits is paramount. ...
(Date:5/22/2013)... iLuv Creative Technology, the premier provider ... mobile lifestyle, announces they are now shipping MultiCharger-X, an ... iPad devices efficiently. Winner of the 2013 internationally recognized ... award, MultiCharger-X is revolutionizing the way businesses, schools, and ... , MultiCharger-X (iAD910) combines the best ...
Breaking Biology Technology:Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 2AfricanAncestry.com Rolls Out Improved MyDNAMix Admixture Test for People of all Races; Enhancements Increase Accuracy in Estimation of Ancestral Makeup 3PHI Emergency Management on Announces Father's Day Specials All Emergency Survival Kits 2iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3
... Cancer is the major cause of death among ... by about 2010, cancer will be the No. 1 ... connected to the Katholieke Universiteit Leuven, in collaboration with ... anti-cancer action of anti-PLGF. This substance appears not only ...
... Rensselaer Polytechnic Institute is leading a $3 million ... most powerful supercomputers to boost the safety and reliability ... funded by the U.S. Department of Energy, will call ... create highly detailed computer models of a new proposed ...
... Nov. 1 Renovis,Inc. (Nasdaq: RNVS ) announced ... the company at the CIBC 18th Annual Healthcare,Conference in ... at 11:30,a.m. Eastern Standard Time (8:30 a.m. PST). The ... broadcast and the subsequent archived audio,recording of the company ...
Cached Biology Technology:On the road to a new cancer therapy -- starving the tumor 2On the road to a new cancer therapy -- starving the tumor 3Using supercomputers to make safer nuclear reactors 2Using supercomputers to make safer nuclear reactors 3Using supercomputers to make safer nuclear reactors 4
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... (May 23, 2013) A new report from the ... helping pupils engage in at least 60 minutes of ... , No more than half of American youth meet ... vigorous or moderate intensity physical activity daily, according to ... children are in school for nearly half of their ...
(Date:5/23/2013)... largest and fastest growing open-access publishers, announces the ... Bioengineering and Biotechnology . , A broad ... Bioengineering and Biotechnology will provide a single ... biotechnology research to be disseminated and discussed. ... will provide an open-science and interactive web platform ...
Breaking Biology News(10 mins):Biochemistry: Unspooling DNA from nucleosomal disks 2Schools should provide students with daily physical activity, IOM recommends 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... This press release is available in French ... of researchers have discovered that, on average, thirty mutations are ... and revolutionizing the timescale we use to calculate the number ... genetic code, is made up of six billion pieces of ...
... sounds like something out of a comic book or a ... is exactly what two investigators at the Wellman Center for ... report that will appear in the journal Nature Photonics ... Gather, PhD, and Seok Hyun Yun, PhD, describe how a ...
... Patriot Scientific Corporation ... its wholly owned subsidiary, Patriot Data Solutions Group ... pilot project for the Louisiana District Attorney Association (LDAA). ... to automate the transmission of the Automated Fingerprint Identification System ...
Cached Biology News:Family genetic research reveals the speed of human mutation 2Single GFP-expressing cell is basis of living laser device 2Single GFP-expressing cell is basis of living laser device 3Patriot Data Solutions Group Selected to Assist Louisiana District Attorney Association with Pilot Project 2Patriot Data Solutions Group Selected to Assist Louisiana District Attorney Association with Pilot Project 3Patriot Data Solutions Group Selected to Assist Louisiana District Attorney Association with Pilot Project 4
The FailSafe™ PROBES Real-Time PCR System enables rapid, precise optimization of PCR experiments in which the product is detected using fluorescent target-specific labeled probes....
Immunofixation Gel Kit, requires IF100 Reactivity: Human Applications: Immunofixation ...
...
...
Biology Products: